Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Alpha-1A adrenergic receptor | ||
| Ligand | BDBM50211347 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_444276 (CHEMBL894516) | ||
| Ki | 3.5±n/a nM | ||
| Citation |  Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS). Bioorg Med Chem Lett17:3292-7 (2007) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Alpha-1A adrenergic receptor | |||
| Name: | Alpha-1A adrenergic receptor | ||
| Synonyms: | ADA1A_HUMAN | ADRA1A | ADRA1C | Adrenergic alpha1A | Alpha 1A-adrenoceptor | Alpha 1A-adrenoreceptor | Alpha adrenergic receptor 1a | Alpha-1C adrenergic receptor | Alpha-adrenergic receptor 1c | Cerebral cortex alpha adrenergic receptor | adrenergic Alpha1 | adrenergic Alpha1C | ||
| Type: | Cell-surface receptors | ||
| Mol. Mass.: | 51511.67 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P35348 | ||
| Residue: | 466 | ||
| Sequence: |
| ||
| BDBM50211347 | |||
| n/a | |||
| Name | BDBM50211347 | ||
| Synonyms: | 5-bromo-6-chloro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)pyridine-3-sulfonamide | CHEMBL233790 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C24H32BrClN4O3S | ||
| Mol. Mass. | 571.958 | ||
| SMILES | CC(C)Oc1ccccc1N1CCN(CC1)[C@H]1CC[C@@H](CC1)NS(=O)(=O)c1cnc(Cl)c(Br)c1 |wU:16.17,wD:19.24,(15.77,-6.17,;14.99,-7.5,;13.45,-7.48,;15.74,-8.84,;14.95,-10.16,;13.42,-10.14,;12.63,-11.47,;13.39,-12.82,;14.93,-12.83,;15.71,-11.51,;17.24,-11.53,;18,-12.86,;19.54,-12.88,;20.32,-11.56,;19.57,-10.22,;18.03,-10.21,;21.85,-11.58,;22.64,-10.26,;24.18,-10.28,;24.93,-11.63,;24.14,-12.95,;22.61,-12.93,;26.49,-11.66,;27.26,-10.33,;25.93,-9.56,;28.59,-11.1,;28.02,-8.99,;29.57,-8.98,;30.33,-7.64,;29.55,-6.32,;30.31,-4.97,;28,-6.33,;27.21,-5.01,;27.25,-7.67,)| | ||
| Structure | 
| ||